194 related articles for article (PubMed ID: 10362118)
1. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver.
Tannapfel A; Engeland K; Weinans L; Katalinic A; Hauss J; Mössner J; Wittekind C
Br J Cancer; 1999 Jun; 80(7):1069-74. PubMed ID: 10362118
[TBL] [Abstract][Full Text] [Related]
2. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver.
Tannapfel A; Weinans L; Geissler F; Schütz A; Katalinic A; Köckerling F; Hauss J; Wittekind C
Dig Dis Sci; 2000 Feb; 45(2):317-24. PubMed ID: 10711445
[TBL] [Abstract][Full Text] [Related]
3. Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Int J Cancer; 2002 May; 99(1):22-8. PubMed ID: 11948487
[TBL] [Abstract][Full Text] [Related]
4. Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.
Zheng T; Wang J; Chen X; Meng X; Song X; Lu Z; Jiang H; Liu L
Tumour Biol; 2010 Aug; 31(4):287-95. PubMed ID: 20422343
[TBL] [Abstract][Full Text] [Related]
5. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma.
Tannapfel A; Wasner M; Krause K; Geissler F; Katalinic A; Hauss J; Mössner J; Engeland K; Wittekind C
J Natl Cancer Inst; 1999 Jul; 91(13):1154-8. PubMed ID: 10393724
[TBL] [Abstract][Full Text] [Related]
6. P73 expression in basal layers of head and neck squamous epithelium: a role in differentiation and carcinogenesis in concert with p53 and p63?
Faridoni-Laurens L; Bosq J; Janot F; Vayssade M; Le Bihan ML; Kaghad M; Caput D; Bénard J; Ahomadegbe JC
Oncogene; 2001 Aug; 20(38):5302-12. PubMed ID: 11536043
[TBL] [Abstract][Full Text] [Related]
7. Expression of the p53 homologues p63 and p73 in multiple simultaneous gastric cancer.
Tannapfel A; Schmelzer S; Benicke M; Klimpfinger M; Kohlhaw K; Mössner J; Engeland K; Wittekind C
J Pathol; 2001 Sep; 195(2):163-70. PubMed ID: 11592094
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
9. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
Wang X; Zhang J; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
[TBL] [Abstract][Full Text] [Related]
10. Genetic alternations of p73 are infrequent but may occur in early stage hepatocellular carcinoma.
Peng CY; Tsai SL; Yeh CT; Hung SP; Chen MF; Chen TC; Chu CM; Liaw YF
Anticancer Res; 2000; 20(3A):1487-92. PubMed ID: 10928060
[TBL] [Abstract][Full Text] [Related]
11. Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer.
Chi SG; Chang SG; Lee SJ; Lee CH; Kim JI; Park JH
Cancer Res; 1999 Jun; 59(12):2791-3. PubMed ID: 10383132
[TBL] [Abstract][Full Text] [Related]
12. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67, Bax and p73 in patients with hilar cholangiocarcinoma.
Zhao W; Zhang B; Guo X; Zhang X; Hu J; Hu X; Lu Y
Cancer Biomark; 2014; 14(4):197-202. PubMed ID: 24934361
[TBL] [Abstract][Full Text] [Related]
14. Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.
Furubo S; Harada K; Shimonishi T; Katayanagi K; Tsui W; Nakanuma Y
Histopathology; 1999 Sep; 35(3):230-40. PubMed ID: 10469215
[TBL] [Abstract][Full Text] [Related]
15. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.
Liu XF; Zhang H; Zhu SG; Zhou XT; Su HL; Xu Z; Li SJ
World J Gastroenterol; 2006 Aug; 12(29):4706-9. PubMed ID: 16937443
[TBL] [Abstract][Full Text] [Related]
16. Effect of Mir-122 on Human Cholangiocarcinoma Proliferation, Invasion, and Apoptosis Through P53 Expression.
Wu C; Zhang J; Cao X; Yang Q; Xia D
Med Sci Monit; 2016 Jul; 22():2685-90. PubMed ID: 27472451
[TBL] [Abstract][Full Text] [Related]
17. p53 Mutations in human cholangiocarcinoma: a review.
Khan SA; Thomas HC; Toledano MB; Cox IJ; Taylor-Robinson SD
Liver Int; 2005 Aug; 25(4):704-16. PubMed ID: 15998419
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of P73 and TP53 in Merkel cell carcinoma.
Van Gele M; Kaghad M; Leonard JH; Van Roy N; Naeyaert JM; Geerts ML; Van Belle S; Cocquyt V; Bridge J; Sciot R; De Wolf-Peeters C; De Paepe A; Caput D; Speleman F
Br J Cancer; 2000 Feb; 82(4):823-6. PubMed ID: 10732753
[TBL] [Abstract][Full Text] [Related]
19. Regulators of apoptosis in cholangiocarcinoma.
Jhala NC; Vickers SM; Argani P; McDonald JM
Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
[TBL] [Abstract][Full Text] [Related]
20. Expression of the putative tumour suppressor gene, p73, in neuroblastoma and other childhood tumours.
Norris MD; Gilbert J; Smith SA; Marshall GM; Salwen H; Cohn SL; Haber M
Med Pediatr Oncol; 2001 Jan; 36(1):48-51. PubMed ID: 11464904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
